Daihan Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
6,460
6,646
11,813
12,363
16,118
Total Accounts Receivable
41,771
44,361
45,025
48,750
50,355
Inventories
8,556
11,737
13,342
12,478
16,913
Other Current Assets
109
30
27
68
86
Total Current Assets
56,896
62,774
70,206
73,659
83,472
Net Property, Plant & Equipment
58,146
64,614
64,089
80,332
93,795
Total Investments and Advances
2,907
3,794
4,103
5,432
5,742
Long-Term Note Receivable
-
9
9
9
9
Intangible Assets
437
422
418
413
409
Other Assets
305
-
-
240
240
Total Assets
121,507
135,265
142,824
160,306
189,899
ST Debt & Current Portion LT Debt
13,447
13,949
8,117
7,800
8,200
Accounts Payable
17,238
18,448
20,420
21,451
17,771
Income Tax Payable
529
2,204
3,065
2,166
5,873
Other Current Liabilities
11,114
8,583
8,547
16,881
11,578
Total Current Liabilities
42,329
43,184
40,150
48,298
43,422
Long-Term Debt
10,059
12,000
10,000
6,800
12,400
Provision for Risks & Charges
8,627
10,807
10,895
11,661
12,088
Deferred Taxes
1,689
982
421
221
736
Other Liabilities
326
543
521
603
613
Total Liabilities
65,846
71,168
65,985
67,363
74,018
Common Equity (Total)
55,661
64,097
76,839
92,943
115,881
Total Shareholders' Equity
55,661
64,097
76,839
92,943
115,881
Total Equity
55,661
64,097
76,839
92,943
115,881
Liabilities & Shareholders' Equity
121,507
135,265
142,824
160,306
189,899
About Daihan Pharmaceutical Co.
View Profile
